Research Progress of Mechanisms of Ceftriaxone Associated Nephrolithiasis

Author(s): Shu Wang, Xiaobo Huang*, Qingquan Xu, Tao Xu.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 17 , Issue 17 , 2017

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Urinary calculi can be caused by a variety of reasons, such as metabolic abnormalities, urinary tract infection and obstruction. Certain medications can induce urinary stone disease. Ceftriaxone, a third generation cephalosporin with broad spectrum antibiotic activity, primarily eliminated by the kidneys, has now been widely used for treatment of infection. It has been long considered safe, especially in children. However, more and more cases about ceftriaxone induced nephrolithiasis as a rare side effect have been reported.

Conclusion: This complication generally resolves spontaneously with cessation of the drug. Severe nephrolithiasis can cause post renal acute renal failure (PARF). There is limited information about how this complication develops, though high doses and extended treatment periods are generally considered to be responsible. Understanding the mechanisms would help the doctors to be aware of this rare complication and respond with proper treatment. The primary goal of this review is to discuss the possible mechanisms based on the most recent literatures.

Keywords: Ceftriaxone, hydronephrosis, mechanism, nephrolithiasis, urinary tract stones, urolithiasis.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 17
ISSUE: 17
Year: 2017
Page: [1584 - 1587]
Pages: 4
DOI: 10.2174/1389557516666160801092713
Price: $58

Article Metrics

PDF: 34
HTML: 1